The clinical pharmacologist in drug regulation: A European perspective

被引:1
|
作者
Rawlins, MD
机构
关键词
drug regulation; clinical pharmacology;
D O I
10.1046/j.1365-2125.1996.03779.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The clinical pharmacologist in drug regulation has many roles to play. These include responsibilities for the premarketing assessment of a new product's efficacy and safety, for scrutiny of the summary of Product Characteristics, and for monitoring its performance after marketing. Furthermore, the clinical pharmacologist has a subsidiary responsibility in examining the results of preclinical pharmacological and toxicological studies. 2 Clinical pharmacologists in regulatory authorities have one further, and crucial, responsibility-humility. From their training and experience they will (or should) know of their own scientific limitations and of the necessity for seeking help and advice from other disciplines.
引用
收藏
页码:59 / 61
页数:3
相关论文
共 50 条
  • [2] Clinical toxicology and drug regulation: A United Kingdom perspective
    Waring, W. Stephen
    McGettigan, Patricia
    CLINICAL TOXICOLOGY, 2011, 49 (06) : 452 - 456
  • [3] Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey
    Krishnamurthy, Manjunath Nookala
    Pradosh, Anupama
    Varghese, Diana
    Halder, Soutik
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 2003 - 2011
  • [4] Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey
    Manjunath Nookala Krishnamurthy
    Anupama Pradosh
    Diana Varghese
    Soutik Halder
    European Journal of Clinical Pharmacology, 2022, 78 : 2003 - 2011
  • [5] The advisory process for anticancer drug regulation: a global perspective
    Farrell, AT
    Papadouli, I
    Hori, A
    Harczy, M
    Harrison, B
    Asakura, W
    Marty, M
    Dagher, R
    Pazdur, R
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 889 - 896
  • [6] Practical aspects of apixaban use in clinical practice: view point of clinical pharmacologist
    Sychev, D. A.
    Sinitsina, I. I.
    Zakharova, G. Yu.
    Savel'eva, M. I.
    Ryabova, A. V.
    Kryukov, A. V.
    Yurovskii, A. Yu.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 209 - 216
  • [7] Quantitative clinical pharmacology is transforming drug regulation
    Peck, Carl C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (06) : 617 - 628
  • [8] Quantitative clinical pharmacology is transforming drug regulation
    Carl C. Peck
    Journal of Pharmacokinetics and Pharmacodynamics, 2010, 37 : 617 - 628
  • [9] Evidence based medicine, RCTs and their natural enemies: the clinical pharmacologist's role
    Eichler, HG
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (01) : 1 - 3
  • [10] A review of clinical pharmacology deficiencies of European centralised drug marketing authorisation applications
    Hay, Justin L.
    O'Sullivan, Jane
    Kerwash, Essam
    Ilie, Alexandra-Roxana
    Cole, Susan M.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 118